Have your say on the National Diabetes Strategy 8 May 2015 Diabetes Victoria CEO Craig Bennett has called on the 300,000 Victorians living with diabetes to actively participate in the formation of the National Diabetes Strategy. People affected by diabetes, health professionals and researchers are encouraged to have their say as the Commonwealth Government consults on the best ways to combat the growing epidemic and help people to better manage this condition. The Commonwealth Minister for Health, the Hon Sussan Ley MP, has released a consultation paper, prepared by the National Diabetes Strategy Advisory Group, as part of the process. The consultation paper can be found at: https://consultations.health.gov.au The consultation phase will close on Sunday 17 May. Unless checked, diabetes will account for the greatest burden of disease in our community by 2017, according to the Australian Institute of Health and Welfare (2010). Diabetes is estimated to cost the Victorian community $3.6 billion a year. “In Victoria we have 74 new cases every day – around 27,000 new diagnoses in 2014. In light of these rapidly increasing numbers we are encouraged that diabetes is on the Commonwealth Government’s agenda,†Mr Bennett said. â€We think that a wide consultation will get the best outcomes for people affected by all types of diabetes and those at risk, including people from different ethnic groups and vulnerable communities,†Mr Bennett said. “We know that the complications of diabetes include heart attack, stroke, kidney damage, blindness and amputation. This wider consultation will help with a strategy to prevent, detect and better manage diabetes in Victoria,†he said. “We look forward to identifying the best way to address the impact of diabetes and build sustainable programs to reduce the impact on Victorian families, workplaces and communities.â€
Blog 27 July 2026 Round up for Diabetes Australia and turn small change into impact Learn how your spare change with Round up goes straight to Diabetes Australia to support programs, research, education, and advocacy. Continue Reading
News 24 July 2026 GLP-1 RA safety update for rare but severe eye disorders The Therapeutic Goods Administration has updated GLP-1 RA product warnings because of their potential to cause a rare but severe eye disorder. The glucagon-like peptide-1 receptor agonist... Continue Reading
Blog 22 July 2026 Living Out Loud: how Australia spoke up for National Diabetes Week 2026 From 12 to 18 July, Australians living with diabetes, alongside their carers, researchers, health professionals and clinicians, did something powerful. They... Continue Reading